ALHC
Alignment Healthcare, Inc.
$19.75
-2.42%
$4.1B
No data for this timeframe.
Vol
Market Cap$4.1B
Cap SizeMid Cap
Analyst ConsensusStrong Buy (85%)
Inst. Holders50 funds
Inst. Value$2.4B
Inst. Activity16 buys / 12 sells
Insider Activity1B / 26S
Insider Net $-$30.8M
SEC Reports19
Press Releases2
Recent Activity
Jun 12, 2026
short_volume
Short Volume: ALHC — 56.8% short (1.1M / 1.9M)
Short: 1,063,818 | Exempt: 12,116 | TRF Vol: 1,874,439 | Short Ratio: 56.8% | Off-exchange volume (d
Jun 11, 2026
SEC
Director Joseph S. Konowiecki filed Form 144 to sell 25,000 shares of Alignment Healthcare common stock, valued at appro
144 — Impact 2/10
Jun 9, 2026
SEC
Alignment Healthcare President Kent Mark D. purchased $198K of ALHC stock on the open market at $13.31/share on June 2,
INSIDER-BUY — Impact 4/10
Jun 3, 2026
Insider
Kent Mark D. was granted 87,719 shares
President - MSO
Jun 3, 2026
Insider
KONOWIECKI JOSEPH S was granted 122,807 shares
EVP, Corporate Affairs
Jun 2, 2026
SEC
Alignment Healthcare published its 2025 Impact Report highlighting reduced high-cost utilization (34% fewer ER visits, 3
PRESS-RELEASE — Impact 2/10
Jun 2, 2026
Insider
Kent Mark D. bought 14,848 shares
President - MSO @ $13.31 ($197.6K)
Inst.
WILLIAM BLAIR INVESTMENT MANAGEMENT, — DOUBLED
5,214,614 shares ($91.9M)
Price Targets
$24.92
+26.2% upside
Strong Buy
Current $19.75
Low $16.00
Median $25.00
High $30.00
13 analysts
$16.00
$30.00
Analyst Ratings
9Strong Buy
8Buy
3Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| May 26, 2026 | Barclays | MAINTAIN | Equal-Weight → Equal-Weight |
| May 1, 2026 | UBS | MAINTAIN | Neutral → Neutral |
| May 1, 2026 | Barclays | MAINTAIN | Equal-Weight → Equal-Weight |
| Feb 5, 2026 | JP Morgan | MAINTAIN | Overweight → Overweight |
| Jan 16, 2026 | TD Cowen | MAINTAIN | Buy → Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $0.20 | $0.19 — $0.21 | 47% YoY | 4 |
| Next Q | $0.14 | $0.11 — $0.16 | 38% YoY | 4 |
| Current FY | $0.47 | $0.47 — $0.48 | 48% YoY | 4 |
| Next FY | $0.72 | $0.66 — $0.78 | 52% YoY | 4 |
Latest Reports
NEUTRAL
144
2/10
Director Joseph S. Konowiecki filed Form 144 to sell 25,000 shares of Alignment Healthcare common stock, valued at appro
Jun 11, 2026
BULLISH
INSIDER-BUY
4/10
Alignment Healthcare President Kent Mark D. purchased $198K of ALHC stock on the open market at $13.31/share on June 2,
Jun 9, 2026
NEUTRAL
Press
4/10
Alignment Healthcare (ALHC) announced the pricing of a public offering of 13,167,733 shares by an affiliate of General A
Mar 3, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP | $301.3M | ADD |
| FMR LLC | $280.0M | ADD |
| BlackRock, Inc. | $248.0M | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $171.1M | — |
| VANGUARD CAPITAL MANAGEMENT LLC | $140.5M | — |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Jun 3, 2026 | Kent Mark | A | $0.00 |
| Jun 3, 2026 | KONOWIECKI JOSEPH | A | $0.00 |
| Jun 2, 2026 | Kent Mark | BUY | $197.6K |
| May 18, 2026 | Maroney Dawn | G | $0.00 |
| May 15, 2026 | Maroney Dawn | SELL | $482.6K |
50 institutional holders with $2.4B total value (135,927,171 shares) as of 2026-Q1. Top holders: WELLINGTON, FMR, BlackRock,. Net buying activity: 16 institutions added/increased vs 12 reduced.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | WELLINGTON MANAGEMENT GROUP LLP | 17,098,936 | $301.3M | 12.6% | ADD +26.9% |
| 2 | FMR LLC | 15,892,064 | $280.0M | 11.7% | ADD +81.4% |
| 3 | BlackRock, Inc. | 14,075,197 | $248.0M | 10.3% | — |
| 4 | VANGUARD PORTFOLIO MANAGEMENT LLC | 9,710,071 | $171.1M | 7.1% | — |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 7,973,663 | $140.5M | 5.9% | — |
| 6 | Invesco Ltd. | 7,000,099 | $123.3M | 5.1% | ADD +38.9% |
| 7 | Hood River Capital Management LLC | 6,054,477 | $106.7M | 4.5% | — |
| 8 | CITADEL ADVISORS LLC | 5,362,666 | $94.5M | 3.9% | — |
| 9 | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 5,214,614 | $91.9M | 3.8% | DOUBLED +126.2% |
| 10 | STATE STREET CORP | 4,293,694 | $75.7M | 3.2% | — |
| 11 | Capital Research Global Investors | 3,593,576 | $63.3M | 2.6% | NEW |
| 12 | BANK OF AMERICA CORP /DE/ | 3,215,667 | $56.7M | 2.4% | DOUBLED +156.5% |
| 13 | RENAISSANCE TECHNOLOGIES LLC | 2,903,100 | $51.2M | 2.1% | — |
| 14 | VOYA INVESTMENT MANAGEMENT LLC | 2,795,706 | $49.3M | 2.1% | — |
| 15 | Capital World Investors | 2,666,058 | $47.0M | 2.0% | NEW |
| 16 | Allspring Global Investments Holdings, LLC | 2,458,400 | $43.9M | 1.8% | DOUBLED +276.7% |
| 17 | Point72 Asset Management, L.P. | 2,439,637 | $43.0M | 1.8% | TRIM -27.7% |
| 18 | LOOMIS SAYLES & CO L P | 2,106,068 | $37.1M | 1.5% | NEW |
| 19 | AMERIPRISE FINANCIAL INC | 2,101,456 | $37.0M | 1.5% | — |
| 20 | Nuveen, LLC | 1,580,582 | $27.8M | 1.2% | TRIM -26.0% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | DOUBLED | 2,305,255 | 5,214,614 | +126.2% | $91.9M | 2026-Q1 |
| Capital Research Global Investors | NEW | — | 3,593,576 | — | $63.3M | 2026-Q1 |
| BANK OF AMERICA CORP /DE/ | DOUBLED | 1,253,889 | 3,215,667 | +156.5% | $56.7M | 2026-Q1 |
| Allspring Global Investments Holdings, LLC | DOUBLED | 652,648 | 2,458,400 | +276.7% | $43.9M | 2026-Q1 |
| Nuveen, LLC | TRIM | 2,137,007 | 1,580,582 | -26.0% | $27.8M | 2026-Q1 |
| MORGAN STANLEY | TRIM | 2,362,546 | 1,526,839 | -35.4% | $26.9M | 2026-Q1 |
| Freestone Grove Partners LP | DOUBLED | 620,210 | 1,337,777 | +115.7% | $23.6M | 2026-Q1 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | DOUBLED | 135,771 | 1,050,174 | +673.5% | $18.5M | 2026-Q1 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | TRIM | 1,705,040 | 759,957 | -55.4% | $13.4M | 2026-Q1 |
| SEI INVESTMENTS CO | ADD | 443,429 | 739,063 | +66.7% | $13.0M | 2026-Q1 |
| ENVESTNET ASSET MANAGEMENT INC | DOUBLED | 23,821 | 551,319 | +2214.4% | $9.7M | 2026-Q1 |
| PRUDENTIAL FINANCIAL INC | TRIM | 487,650 | 336,980 | -30.9% | $5.9M | 2026-Q1 |
| BNP Paribas Asset Management Holding S.A. | ADD | 246,851 | 327,009 | +32.5% | $5.8M | 2026-Q1 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | DOUBLED | 107,587 | 238,139 | +121.3% | $4.2M | 2026-Q1 |
| MARSHALL WACE, LLP | DOUBLED | 17,131 | 237,656 | +1287.3% | $4.2M | 2026-Q1 |
| Jain Global LLC | ADD | 111,989 | 152,922 | +36.6% | $2.7M | 2026-Q1 |
| Assenagon Asset Management S.A. | NEAR_EXIT | 1,774,975 | 152,846 | -91.4% | $2.7M | 2026-Q1 |
| Universal- Beteiligungs- und Servicegesellschaft mbH | DOUBLED | 47,432 | 149,892 | +216.0% | $2.6M | 2026-Q1 |
| Verition Fund Management LLC | TRIM | 236,250 | 118,310 | -49.9% | $2.1M | 2026-Q1 |
| BALYASNY ASSET MANAGEMENT L.P. | NEAR_EXIT | 600,462 | 93,678 | -84.4% | $1.7M | 2026-Q1 |
| Trexquant Investment LP | NEAR_EXIT | 583,929 | 53,407 | -90.9% | $941.0K | 2026-Q1 |
| Russell Investments Group, Ltd. | TRIM | 85,557 | 40,446 | -52.7% | $712.7K | 2026-Q1 |
| CANADA PENSION PLAN INVESTMENT BOARD | TRIM | 63,500 | 36,900 | -41.9% | $650.2K | 2026-Q1 |
| XPONANCE LLC | ADD | 13,416 | 17,839 | +33.0% | $314.3K | 2026-Q1 |
| Brevan Howard Capital Management LP | TRIM | 25,401 | 12,870 | -49.3% | $226.8K | 2026-Q1 |
18 unique insiders with 49 transactions. Net insider value: -$30.8M ($197.6K bought, $31.0M sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 3, 2026 | Kent Mark D. | President - MSO | AWARD | 87,719 | — | — |
| Jun 3, 2026 | KONOWIECKI JOSEPH S | EVP, Corporate Affairs | AWARD | 122,807 | — | — |
| Jun 2, 2026 | Kent Mark D. | President - MSO | BUY | 14,848 | $13.31 | $197.6K |
| May 18, 2026 | Maroney Dawn Christine | President | GIFT | 20,000 | — | — |
| May 15, 2026 | Maroney Dawn Christine | President | SELL | 30,000 | $16.09 | $482.6K |
| May 15, 2026 | Maroney Dawn Christine | President | GIFT | 1,500 | — | — |
| May 11, 2026 | KAO JOHN E | Chief Executive Officer | SELL | 280,893 | $16.85 | $4.7M |
| Apr 15, 2026 | Maroney Dawn Christine | President | SELL | 30,000 | $20.87 | $626.2K |
| Apr 13, 2026 | KAO JOHN E | Chief Executive Officer | SELL | 82,299 | $20.80 | $1.7M |
| Apr 10, 2026 | KAO JOHN E | Chief Executive Officer | SELL | 201,900 | $20.58 | $4.2M |
| Apr 7, 2026 | KAO JOHN E | Chief Executive Officer | SELL | 132,241 | $20.67 | $2.7M |
| Apr 7, 2026 | Head James M | Chief Financial Officer | SELL | 11,100 | $21.08 | $234.0K |
| Apr 1, 2026 | JOYCE CHRISTOPHER J | Chief Legal and Admin. Officer | SELL | 18,013 | $17.79 | $320.5K |
| Mar 23, 2026 | KAO JOHN E | Chief Executive Officer | SELL | 118,000 | $17.48 | $2.1M |
| Mar 19, 2026 | Wagner Andreas P. | Chief Human Resources Officer | SELL | 11,602 | $18.22 | $211.4K |
| Mar 18, 2026 | Burzacchi Sebastian | COO - Mgmt Services Org | SELL | 15,361 | $17.84 | $274.0K |
| Mar 18, 2026 | JOYCE CHRISTOPHER J | Chief Legal and Admin. Officer | SELL | 25,125 | $17.84 | $448.2K |
| Mar 18, 2026 | Maroney Dawn Christine | President | SELL | 36,749 | $17.84 | $655.6K |
| Mar 18, 2026 | Wagner Andreas P. | Chief Human Resources Officer | SELL | 12,000 | $17.84 | $214.1K |
| Mar 18, 2026 | Scavo Robert L. | Chief Information Officer | SELL | 11,285 | $17.84 | $201.3K |
| Mar 18, 2026 | Kim Hyong | Chief Medical Officer | SELL | 18,404 | $17.84 | $328.3K |
| Mar 18, 2026 | KAO JOHN E | Chief Executive Officer | SELL | 73,046 | $17.84 | $1.3M |
| Mar 16, 2026 | Maroney Dawn Christine | President | SELL | 30,000 | $17.48 | $524.4K |
| Mar 13, 2026 | Maroney Dawn Christine | President | AWARD | 161,860 | — | — |
| Mar 13, 2026 | McCarthy Margaret M | Director | AWARD | 14,273 | — | — |
| Mar 13, 2026 | BILNEY JODY L | Director | AWARD | 16,039 | — | — |
| Mar 13, 2026 | HODGSON DAVID C | Director | AWARD | 18,982 | — | — |
| Mar 13, 2026 | KONOWIECKI JOSEPH S | Director | AWARD | 24,868 | — | — |
| Mar 13, 2026 | JORDEN YON | Director | AWARD | 13,096 | — | — |
| Mar 13, 2026 | KOSECOFF JACQUELINE B | Director | AWARD | 13,096 | — | — |
| Mar 13, 2026 | McClellan Mark B. | Director | AWARD | 13,096 | — | — |
| Mar 13, 2026 | Vorhoff Nicholas Robbert | Director | AWARD | 18,982 | — | — |
| Mar 13, 2026 | KAO JOHN E | Chief Executive Officer | AWARD | 338,434 | — | — |
| Mar 13, 2026 | Head James M | Chief Financial Officer | AWARD | 103,002 | — | — |
| Mar 13, 2026 | JOYCE CHRISTOPHER J | Chief Legal and Admin. Officer | AWARD | 51,501 | — | — |
| Mar 13, 2026 | Kim Hyong | Chief Medical Officer | AWARD | 52,972 | — | — |
| Mar 13, 2026 | Burzacchi Sebastian | COO - Mgmt Services Org | AWARD | 36,198 | — | — |
| Mar 13, 2026 | Mansour Adnan R. | Chief Digital Officer | AWARD | 25,015 | — | — |
| Mar 13, 2026 | Wagner Andreas P. | Chief Human Resources Officer | AWARD | 23,543 | — | — |
| Mar 12, 2026 | KAO JOHN E | Chief Executive Officer | SELL | 45,938 | $17.48 | $802.8K |
| Mar 12, 2026 | Maroney Dawn Christine | President | SELL | 27,350 | $17.48 | $478.0K |
| Mar 12, 2026 | Scavo Robert L. | Chief Information Officer | SELL | 3,799 | $17.48 | $66.4K |
| Mar 10, 2026 | KAO JOHN E | Chief Executive Officer | SELL | 180,000 | $18.19 | $3.3M |
| Mar 10, 2026 | Maroney Dawn Christine | President | GIFT | 4,200 | — | — |
| Mar 4, 2026 | Wagner Andreas P. | Chief Human Resources Officer | SELL | 21,118 | $18.62 | $393.3K |
| Feb 23, 2026 | Mansour Adnan R. | Chief Digital Officer | AWARD | 23,441 | — | — |
| Feb 17, 2026 | Maroney Dawn Christine | President | SELL | 30,000 | $20.63 | $619.0K |
| Feb 10, 2026 | KAO JOHN E | Chief Executive Officer | SELL | 180,000 | $20.49 | $3.7M |
| Feb 10, 2026 | Wagner Andreas P. | Chief Human Resources Officer | SELL | 22,238 | $20.47 | $455.2K |
19 SEC filing reports analyzed. Sentiment: 3 bullish, 8 bearish, 0 mixed, 8 neutral. Avg impact: 4.9/10.
NEUTRAL
144
2/10
Director Joseph S. Konowiecki filed Form 144 to sell 25,000 shares of Alignment Healthcare common st
Jun 11, 2026
BULLISH
INSIDER-BUY
4/10
Alignment Healthcare President Kent Mark D. purchased $198K of ALHC stock on the open market at $13.
Jun 9, 2026
NEUTRAL
PRESS-RELEASE
2/10
Alignment Healthcare published its 2025 Impact Report highlighting reduced high-cost utilization (34
Jun 2, 2026
BEARISH
CLUSTER
5/10
CEO John Kao sold $4.73M and President Dawn Maroney sold $483K in open-market sales within a week, t
May 19, 2026
NEUTRAL
144
3/10
Director and Officer John E. Kao filed a Form 144 to sell 596,000 shares of Alignment Healthcare (AL
May 11, 2026
BULLISH
8-K
8/10
Alignment Healthcare reported Q1 2026 results with total revenue of $1.235 billion, up 33.3% YoY, an
Apr 30, 2026
NEUTRAL
DEFA14A
3/10
Analysis based on filing metadata only — document content was unavailable
Apr 24, 2026
BEARISH
CLUSTER
7/10
Alignment Healthcare CEO John Kao and President Dawn Maroney sold shares worth $2.34 million in a co
Apr 16, 2026
BEARISH
CLUSTER
7/10
Alignment Healthcare CEO John Kao and CFO James Head sold a combined $4.39 million in shares over a
Apr 13, 2026
BEARISH
PRESS-RELEASE
5/10
Alignment Healthcare (ALHC) announced it will release Q1 2026 financial results on April 30, 2026, w
Apr 9, 2026
NEUTRAL
144
3/10
John E. Kao, a director and officer of Alignment Healthcare, filed a Form 144 to report the intent t
Apr 7, 2026
NEUTRAL
144
3/10
Christopher J. Joyce, an officer of Alignment Healthcare, filed a Form 144 indicating an intent to s
Apr 1, 2026
BEARISH
CLUSTER
7/10
Multiple C-suite executives at Alignment Healthcare (ALHC) sold shares in a concentrated 7-day windo
Mar 23, 2026
NEUTRAL
CLUSTER
4/10
Alignment Healthcare executives, including CEO John Kao and President Dawn Maroney, conducted open-m
Mar 17, 2026
BEARISH
CLUSTER
6/10
Three executives at Alignment Healthcare, including CEO John Kao and President Dawn Maroney, conduct
Mar 17, 2026
BEARISH
CLUSTER
7/10
Multiple C-suite executives at Alignment Healthcare (ALHC) sold shares in a concentrated 7-day windo
Mar 13, 2026
BEARISH
CLUSTER
6/10
Two executives at Alignment Healthcare sold shares in the past week, including CEO John Kao who sold
Mar 10, 2026
NEUTRAL
8-K
5/10
Alignment Healthcare, Inc. (ALHC) is not raising capital, but a major shareholder, General Atlantic
Mar 4, 2026
BULLISH
INST-CLUSTER
6/10
Three major passive institutional investors — Morgan Stanley, Wells Fargo, and UBS — increased their
Feb 28, 2026
Current analyst consensus: Strong Buy (85% buy). Based on 20 analysts: 9 strong buy, 8 buy, 3 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$24.92 mean target
+26.2% upside
Strong Buy (1.43)
$16.00 Low
$30.00 High
| Metric | Value |
|---|---|
| Current Price | $19.75 |
| Target Low | $16.00 |
| Target Mean | $24.92 |
| Target Median | $25.00 |
| Target High | $30.00 |
| # Analysts | 13 |
| Recommendation | Strong Buy (1.43) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.20 | $0.19 | $0.21 | 46.5% | +0.0% | 2↑ 2↓ | $1.3B | 29.0% | 4 |
| Next Q 2026-09-30 |
$0.14 | $0.11 | $0.16 | 37.6% | +0.0% | 0↑ 2↓ | $1.3B | 32.4% | 4 |
| Current FY 2026-12-31 |
$0.47 | $0.47 | $0.48 | 47.8% | — | 2↑ 1↓ | $5.2B | 31.3% | 4 |
| Next FY 2027-12-31 |
$0.72 | $0.66 | $0.78 | 52.1% | +0.0% | 2↑ 0↓ | $6.5B | 25.5% | 4 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $0.203 | |
| 7d ago | $0.203 | |
| 30d ago | $0.203 | |
| 60d ago | $0.200 | +0.003 |
| 90d ago | $0.200 | +0.003 |
5 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 0 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| May 26, 2026 | Barclays | MAINTAIN | Equal-Weight | Equal-Weight |
| May 1, 2026 | UBS | MAINTAIN | Neutral | Neutral |
| May 1, 2026 | Barclays | MAINTAIN | Equal-Weight | Equal-Weight |
| Feb 5, 2026 | JP Morgan | MAINTAIN | Overweight | Overweight |
| Jan 16, 2026 | TD Cowen | MAINTAIN | Buy | Buy |
| Jan 14, 2026 | UBS | MAINTAIN | Neutral | Neutral |
| Jan 6, 2026 | Piper Sandler | MAINTAIN | Overweight | Overweight |
| Dec 17, 2025 | JP Morgan | MAINTAIN | Overweight | Overweight |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 9 | 8 | 3 | 0 | 0 | 85% | |
| May 1, 2026 | 9 | 8 | 3 | 0 | 0 | 85% | |
| Apr 1, 2026 | 8 | 8 | 3 | 0 | 0 | 84% | |
| Mar 1, 2026 | 8 | 8 | 3 | 0 | 0 | 84% | |
| Feb 1, 2026 | 8 | 8 | 3 | 0 | 0 | 84% | |
| Jan 1, 2026 | 8 | 8 | 3 | 0 | 0 | 84% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
Jun 12, 2026
short_volume
Short Volume: ALHC — 56.8% short (1.1M / 1.9M)
Short: 1,063,818 | Exempt: 12,116 | TRF Vol: 1,874,439 | Short Ratio: 56.8% | Off-exchange volume (dark pool + OTC)
Jun 11, 2026
short_volume
Short Volume: ALHC — 57.0% short (1.4M / 2.5M)
Short: 1,418,173 | Exempt: 44,089 | TRF Vol: 2,487,332 | Short Ratio: 57.0% | Off-exchange volume (dark pool + OTC)
Jun 10, 2026
short_volume
Short Volume: ALHC — 75.4% short (4.7M / 6.2M)
Short: 4,703,342 | Exempt: 557,223 | TRF Vol: 6,236,833 | Short Ratio: 75.4% | Off-exchange volume (dark pool + OTC)
Jun 9, 2026
short_volume
Short Volume: ALHC — 68.6% short (5.2M / 7.6M)
Short: 5,226,890 | Exempt: 129,754 | TRF Vol: 7,618,562 | Short Ratio: 68.6% | Off-exchange volume (dark pool + OTC)
Jun 8, 2026
short_volume
Short Volume: ALHC — 63.7% short (0.8M / 1.3M)
Short: 829,600 | Exempt: 3,073 | TRF Vol: 1,302,789 | Short Ratio: 63.7% | Off-exchange volume (dark pool + OTC)
Jun 5, 2026
short_volume
Short Volume: ALHC — 67.3% short (0.9M / 1.4M)
Short: 926,463 | Exempt: 0 | TRF Vol: 1,376,119 | Short Ratio: 67.3% | Off-exchange volume (dark pool + OTC)
Jun 4, 2026
short_volume
Short Volume: ALHC — 70.3% short (1.9M / 2.7M)
Short: 1,892,265 | Exempt: 101,420 | TRF Vol: 2,691,015 | Short Ratio: 70.3% | Off-exchange volume (dark pool + OTC)
Jun 3, 2026
other
Alignment Healthcare Named to the Fortune 1000 2026 List for Second Consecutive Year
The company rises 196 spots to No. 791 on the Fortune 1000 2026 list following continued growth and momentum <pre>The company rises 196 spots to No. 7
Jun 3, 2026
short_volume
Short Volume: ALHC — 65.8% short (2.7M / 4.0M)
Short: 2,656,411 | Exempt: 334,853 | TRF Vol: 4,034,395 | Short Ratio: 65.8% | Off-exchange volume (dark pool + OTC)
Jun 2, 2026
earnings
Alignment Healthcare Shows How Earlier, Coordinated Care Leads to Better Health and Fewer Emergencies in 2025 Impact Report
Fifth annual report introduces refreshed impact strategy, aligned with long-term, responsible growth <pre>Fifth annual report introduces refreshed imp
May 29, 2026
short_volume
Short Volume: ALHC — 79.0% short (1.7M / 2.2M)
Short: 1,744,087 | Exempt: 24 | TRF Vol: 2,207,808 | Short Ratio: 79.0% | Off-exchange volume (dark pool + OTC)
May 28, 2026
short_volume
Short Volume: ALHC — 59.9% short (1.4M / 2.3M)
Short: 1,368,006 | Exempt: 1,837 | TRF Vol: 2,282,917 | Short Ratio: 59.9% | Off-exchange volume (dark pool + OTC)
May 27, 2026
short_volume
Short Volume: ALHC — 77.2% short (0.8M / 1.0M)
Short: 770,873 | Exempt: 26 | TRF Vol: 998,890 | Short Ratio: 77.2% | Off-exchange volume (dark pool + OTC)
May 26, 2026
short_volume
Short Volume: ALHC — 64.5% short (0.6M / 0.9M)
Short: 572,227 | Exempt: 0 | TRF Vol: 887,300 | Short Ratio: 64.5% | Off-exchange volume (dark pool + OTC)
May 22, 2026
short_volume
Short Volume: ALHC — 69.8% short (0.6M / 0.9M)
Short: 608,090 | Exempt: 0 | TRF Vol: 870,820 | Short Ratio: 69.8% | Off-exchange volume (dark pool + OTC)